FIELD: medicine.
SUBSTANCE: invention can be used in treating migraine. Method for selecting migraine therapeutic approach includes analysing blood serum for IgG- and IgA-antigliadin antibodies and IgA-antibodies to tissue transglutaminase. In presence of IgG- and IgA-antigliadin antibodies and IgA-antibodies to tissue transglutaminase patient is prescribed a gluten-free diet, drug therapy administered in absence of antibodies.
EFFECT: use of invention provides high accuracy of choosing migraine therapeutic approach.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING EPISODIC MIGRAINES | 2021 |
|
RU2781099C1 |
COMBINATION THERAPY OF CHILDREN SUFFERING FROM CELIAC DISEASE AT HEALTH RESORT STAGE | 2007 |
|
RU2356244C1 |
METHOD OF SELECTING TACTICS OF TREATING TENSION HEADACHE | 2011 |
|
RU2468746C1 |
METHOD OF TREATING PATIENTS WITH TENSION HEADACHE | 2018 |
|
RU2680894C1 |
METHOD FOR TREATING THE CASES OF HEADACHE STRESS | 2000 |
|
RU2170597C1 |
METHOD OF GEE'S DISEASE DIAGNOSTICS | 2015 |
|
RU2613877C1 |
METHOD OF ASSESSING COMPLIANCE WITH A GLUTEN-FREE DIET IN PATIENTS WITH GLUTEN-SENSITIVE CELIAC DISEASE | 2022 |
|
RU2800820C1 |
METHOD OF IRRITABLE BOWEL ON HEALTH RESORT | 2007 |
|
RU2350341C1 |
METHOD FOR CORRECTION OF PSYCHOSOMATIC DISEASES IN PATIENTS WITH IRRITATED BOWEL SYNDROME | 2017 |
|
RU2637628C1 |
METHOD OF GEE'S DISEASE DIAGNOSTICS | 2007 |
|
RU2333491C1 |
Authors
Dates
2016-03-27—Published
2014-12-22—Filed